Impaired absorption of insulin aspart from lipohypertrophic injection sites

被引：108
作者：
Johansson, UB
Amsberg, S
Hannerz, L
Wredling, R
Adamson, U
Arnqvist, HJ
Lins, PE
机构：
[1] Sophiahemmet Univ Coll, SE-11486 Stockholm, Sweden
[2] Danderyd Hosp, Dept Med, Karolinska Inst, Danderyd Hosp, Stockholm, Sweden
[3] Karolinska Inst, Dept Nursing, Stockholm, Sweden
[4] Linkoping Univ, Fac Hlth Sci, Dept Med & Surg, Div Cell Biol, Linkoping, Sweden
来源：
DIABETES CARE | 2005年 / 28卷 / 08期
关键词：
D O I：
10.2337/diacare.28.8.2025
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2025 / 2027
页数：3
相关论文
共 12 条
[1]  
Alemzadeh Ramin, 2003, Diabetes Technol Ther, V5, P167, DOI 10.1089/152091503321827821
[2]  
ARNQVIST H, 1987, CLIN CHEM, V33, P93
[3]   ABSORPTION KINETICS OF SUBCUTANEOUSLY INJECTED INSULIN - EVIDENCE FOR DEGRADATION AT THE INJECTION SITE [J].
BERGER, M ;
HALBAN, PA ;
GIRARDIER, L ;
SEYDOUX, J ;
OFFORD, RE ;
RENOLD, AE .
DIABETOLOGIA, 1979, 17 (02) :97-99
[4]   Lesson of the week - Poor glycaemic control caused by insulin induced lipohypertrophy [J].
Chowdhury, TA ;
Escudier, V .
BRITISH MEDICAL JOURNAL, 2003, 327 (7411) :383-384
[5]   CLINICALLY IMPORTANT DIFFERENCES IN INSULIN ABSORPTION FROM ABDOMEN IN IDDM [J].
FRID, A ;
LINDE, B .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1993, 21 (2-3) :137-141
[6]   Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors [J].
Hauner, H ;
Stockamp, B ;
Haastert, B .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1996, 104 (02) :106-110
[7]  
Ibarra LS -D, 1998, PRACT DIABETES INT, V15, P9, DOI DOI 10.1002/PDI.1960150108
[8]   Lipohypertrophy in young patients with type 1 diabetes [J].
Kordonouri, O ;
Lauterborn, R ;
Deiss, D .
DIABETES CARE, 2002, 25 (03) :634-634
[9]   Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs [J].
Lindström, T ;
Hedman, CA ;
Arnqvist, HJ .
DIABETES CARE, 2002, 25 (06) :1049-1054
[10]  
REACH G, 1993, DIABETES METAB, V19, P195
12